ARKO vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARKO's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 7.02. While the stock trades below its Graham Number ($2.85) and intrinsic value ($1.05), it is currently priced at $5.26—well above both, suggesting a significant premium driven by speculative growth expectations. Despite strong earnings surprises in recent quarters and a 'strong_buy' analyst consensus, the company exhibits negative revenue growth (-10.7% YoY), deteriorating profitability, and a high payout ratio of 80%, undermining sustainability. The technical trend is bearish (0/100), reinforcing downward momentum.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
ARKO vs TSLA: Head-to-Head Comparison
This page compares Arko Corp. (ARKO) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.